Pancreatic Cancer Research

ResearcherKaohsiung Medical UniversityActive in the last 2 years

Wan-Chi Tsai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4490-3581; OpenAlex author ID A5040995491. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. HMTA, a natural alkylphenol from Ardisia virens Kurz, obstructs autophagic flux to exert anti-pancreatic cancer activity. Last author DOI 10.62347/tvyx8770↗
  2. Taming Pancreatic Cancer: Ardisia virens Kurz-Derived 4-Hydroxy-2-Methoxy-6-Tridecylphenyl Acetate as a Potent Tubulin Polymerization Inhibitor for Targeted Pa… Last author DOI 10.7150/ijms.104112↗
  3. 5-epi-Sinuleptolide from Soft Corals of the Genus Sinularia Exerts Cytotoxic Effects on Pancreatic Cancer Cell Lines via the Inhibition of JAK2/STAT3, AKT, and… Co-author DOI 10.3390/molecules26226932↗
  4. Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways. Last author DOI 10.1371/journal.pone.0183368↗
  5. Ovatodiolide of Anisomeles indica Exerts the Anticancer Potential on Pancreatic Cancer Cell Lines through STAT3 and NF-κB Regulation. Last author DOI 10.1155/2016/8680372↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yu-Fang Chuang · 1 shared paper, 2026 · strength 0.50
  2. Yi-Jin Chen · 2 shared papers, 2017–2025 · strength 0.32
  3. Chien‐Ju Lin · 1 shared paper, 2025 · strength 0.25
  4. Chia‐Hung Yen · 1 shared paper, 2025 · strength 0.25
  5. Jyh‐Horng Sheu · 1 shared paper, 2021 · strength 0.17
  6. Ya‐Ju Hsieh · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.